Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

PHASE1

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Initial version of the protocol not submitted and new version approved has a new sponsor and it has been added into Clinicaltrials by the new sponsor

Conditions

Sarcoma

Interventions

BIOLOGICAL: Autologous CIK Dose level 1
BIOLOGICAL: Autologous CIK Dose level 2
BIOLOGICAL: Autologous CIK Dose level 3
BIOLOGICAL: Autologous CIK Dose level 4

Sponsor

Italian Sarcoma Group

Collaborators

[object Object]